Yanagisawa, Takafumi http://orcid.org/0000-0002-7410-0712
Kimura, Takahiro
Hata, Kenichi
Narita, Shintaro
Hatakeyama, Shingo
Mori, Keiichiro
Sano, Takayuki
Otsuka, Takashi
Iwamoto, Yuya
Enei, Yuki
Nakazono, Minoru
Sakanaka, Keigo
Iwatani, Kosuke
Matsukawa, Akihiro
Atsuta, Mahito
Nishikawa, Hideomi
Tsuzuki, Shunsuke
Miki, Jun
Habuchi, Tomonori
Ohyama, Chikara
Shariat, Shahrokh F.
Egawa, Shin
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 29 January 2022
Accepted: 24 April 2022
First Online: 21 May 2022
Declarations
:
: ć»Takahiro Kimura is a paid consultant/advisor of Astellas, Bayer, Janssen, and Sanofi. Shintaro Narita received honoraria from Janssen Pharmaceutical K.K., Bayer AG. Dr., AstraZeneca K.K., Takeda Pharmaceutical Company Ltd., Sanofi S.A., Astellas Pharma Inc., and grants for research from Novartis Pharmaceuticals. Shingo Hatakeyama received honoraria from Janssen Pharmaceutical K.K. and Pfizer Inc. Department of Advanced Blood Purification Therapy is an endowment department, supported by a grant from NIPRO Corporation. Tomonori Habuchi received honoraria from Janssen Pharmaceutical K.K., Takeda Pharmaceutical Company Ltd., Astellas Pharma Inc., Daiichi Sankyo Company, Ltd., AstraZeneca K.K., Sanofi S.A., and Bayer AG. Chikara Ohyama received honoraria from Astellas Pharma Inc., NIPPON SHINYAKU Company Ltd., AstraZeneca K.K., Janssen Pharmaceutical K.K., Takeda Pharmaceutical Company Ltd., Novartis Pharma K.K., ONO Pharmaceutical Company Ltd., Chugai Pharmaceutical Company Ltd., Sanofi S.A., Bayer AG., Pfizer Inc., Bristol Myers Squibb, Otsuka Pharmaceutical Company Ltd., KISSEI Pharmaceutical Company Ltd., Kyowa Kirin Company Ltd., Daiichi Sankyo Company Ltd., KANEKA Corporation, and Nipro Corporation. Shahrokh F. Shariat received as follows: Honoraria: Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Roche, and Takeda Consulting or Advisory Role: Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Pierre Fabre, Roche, and Takeda Speakers Bureau: Astellas, Astra Zeneca, Bayer, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Richard Wolf, Roche, and Takeda Shin Egawa is a paid consultant/advisor of Takeda, Astellas, AstraZeneca, Sanofi, Janssen, and Pfizer. The other authors declare no conflicts of interest associated with this manuscript.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.